Latest California Healthline Stories
Late Move To Dump ‘Essential’ Benefits Could Strand Chronically Ill
Republicans seek lower cost and more choice for health insurance sold to individuals, but cutting coverage standards could leave fewer comprehensive plans, analysts say.
How Millennials Win And Lose Under The GOP Health Bill
The cost of insurance could go down for people ages 26 to 29 under the GOP plan. But will they buy it without a mandate?
California Estimates It Ultimately Would Lose $24B Annually Under GOP Health Plan
“It’s challenging to see how it would not … jeopardize the entire [Medicaid] program,” a top health official said.
Trump’s Promise To Rein In Drug Prices Could Open Floodgate To Importation Laws
Sen. Bernie Sanders’ bill to allow Americans to buy cheaper medicines from Canada would bypass a requirement that blocked past legislative efforts over two decades.
GAO To Launch Investigation Of FDA’s Orphan Drug Program
The Government Accountability Office said it will investigate potential abuses of the orphan drug program, which offers incentives to drugmakers to develop medicines for rare diseases.
Prescription Drug Costs Are On The Rise; So Are The TV Ads Promoting Them
Spending on consumer advertising by drugmakers has increased 62 percent since 2012.
GOP Bill’s Unheralded Changes In Rules Could Undermine Health And Prospects Of Neediest
Lesser-known provisions in the Republican proposal to replace the Affordable Care Act would push some Medicaid enrollees out of coverage and cause financial pain for others.
On Medicaid Money, GOP Has Win-Or-Lose Proposition For States
The House Republicans’ bill to repeal Obamacare would change how the federal government allocates matching funds to state Medicaid programs — and could cost some states billions of dollars a year in federal aid.
Top Research Centers Call Trump’s Proposed NIH Cuts ‘Shocking’
Research institutions that stand to lose the most include UCSF, Stanford University and UC San Diego. Total NIH funding for the University of California system reached nearly $2 billion in fiscal year 2016.
Cholesterol Drug Prevents Heart Attacks — But It Doesn’t Come Cheap
A cholesterol-lowering drug called Repatha cuts the risk of heart attacks, strokes and heart-related death by 20 percent, according to a new study.